Skip to main content
Mark Faries, MD, General Surgery, Los Angeles, CA

Mark B Faries MD

Melanoma, Surgical Oncology (Other than Breast)


The Angeles Clinic and Research Institute / Cedars Sinai

Join to View Full Profile
  • 11800 Wilshire BlvdFl 3Los Angeles, CA 90025

  • Phone+1 310-967-1884

  • Fax+1 310-967-1744

Dr. Faries is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Surgery, 1995 - 2002
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2028
  • CT State Medical License
    CT State Medical License 2010 - 2015
  • PA State Medical License
    PA State Medical License 1996 - 2004
  • Surgery
    American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Microsatellitosis in Patients with Melanoma  
    Richard L White, Mark B Faries, Stanley P Leong, Andrew J Sinnamon, Jane L Messina, Barbara A Pockaj, Giorgos C Karakousis, Edmund K Bartlett, John T Vetto, Vernon K S..., Annals of Surgical Oncology

Press Mentions

  • GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers Symposium
    GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers SymposiumDecember 13th, 2019
  • Elios Therapeutics Announced That a Personalized Vaccine Reduced the Risk of Melanoma Recurrence in Patients with Previously Treated Disease
    Elios Therapeutics Announced That a Personalized Vaccine Reduced the Risk of Melanoma Recurrence in Patients with Previously Treated DiseaseJuly 17th, 2019
  • Lymph-Node Dissection Increases Rates of Regional Disease Control
    Lymph-Node Dissection Increases Rates of Regional Disease ControlSeptember 1st, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: